A simple, selective, linear, precise, and accurate RP-HPLC method was developed and validated for the simultaneous estimation of Gabapentin & Methylcobalamin from bulk and formulation. Chromatographic separation was achieved Isocratically on an Inertsil C18 column (150x4.6, 5µ particle size) using a mobile phase Buffer: Acetonitrile in the ratio of 60:40 v/v. The flow rate was 1.0 ml/min, effluents were detected at 264 nm and 10µl of sample was injected. Retention time of Gabapentin & Methylcobalamin was found to be 2.7 and 4.13 min respectively. Linearity of the method was in the concentration range of 25-150 µg for Gabapentin & 0.125-0.750 µg for Methylcobalamin. Percent recoveries obtained for both the drugs were 100.00%. The percentage RSD for precision of the method was found to be less than 2%. The method was validated according to the ICH guidelines. The method developed was successfully applied for the analysis of simultaneous estimation of Gabapentin & Methylcobalamin tablets and was fairly good in comparison with other methods.
INTRODUCTION
Gabapentin is ( Figure 1 ) is 1-(amino methyl) cyclo hexane acetic acid. It is an anticonvulsant drug for neuropathic pain and adjunct for seizures. It can be used in generalized anxiety disorders. Methylcobalamin ( Figure 2 ) is α- (5, 6 dimethyl benzimidazol) cobalmid cyanide (3+). It is a form of Vit-B12.It is a water soluble vitamin with a key role in the normal functioning of brain, and nervous system. It has been shown to protect those who take it from neurological conditions and ageing in a way that it makes different from other drugs or therapy [1] [2] [3] [4] . 
Preparation of mobile phase:
Mixture of Buffer and Acetonitrile (60:40 ratios) was sonicated and the resulting solution was degassed by vacuum filtration through 0.4 micron membrane filter.
Preparation of standard stock solutions:
Gabapentin working standard 100 mg was weighed and transferred along with 0.5 of mg of Methylcobalamine working standard into 100 ml volumetric flask, diluent was added for making up volume. The resultant solution was sonicated.
Standard preparation:
One ml of standard stock solution was transferred into 10 ml volumetric flask and diluted to volume with diluent.
Preparation of sample solution:
Pre weighed 20 Tablets were finely triturated. Finely grinded sample quantitatively equivalent to 100 mg of Gabapentin and 0.5 mg of Methylcobalamine was transferred into 10 ml volumetric flask; 25 ml of diluents was added. The resultant was sonicated for 10 minutes and diluted to volume with diluent. Further the solution was filtered through filter paper. Ten ml of filtrate was diluted to 100 ml with mobile phase.
Method development:
After various trials, the following chromatographic conditions were finally optimized for the simultaneous estimation of Gabapentin & Methylcobalamine in a tablet dosage form. Mobile phase constitutes of Buffer: Acetonirile in the ratio of 60:40 v/v. Detection wave length 264 nm flow rate 1.0 ml/min, after a steady baseline the standard solution were injected and chromatograms were recorded until the reproducibility of the peak areas were found and finally 100 μg/ml of the standard solution of the individual samples of Gabapentin and Methylcobalamine and mixed standard solutions were injected and the chromatograms were recorded. The separation of Gabapentin and Methylcobalamine was observed with retention times of 2.7 and 4.13 min respectively. The typical chromatograms of the standard solutions were recorded for the repeatability and the respective chromatogram was given in Figure 3 . 
Method validation:
The proposed method was validated as per ICH guidelines. 
Linearity:
The linearity range was found to be from 25 µg to 150 µg for Gabapentin and 0.125 µg to 0.75 µg for Methylcobalamin. Accuracy of the assay method was evaluated in triplicate using three concentration levels 80, 100 and 120μg/ml on real sample (tablets). Standard addition and recovery experiments were conducted on real sample to determine accuracy the method. Study was carried out in triplicate using three (80, 100 and 120%) concentration levels. The percentages of recoveries for Gabapentin and Methylcobalamin were calculated. 
Robustness:
To determine the robustness of the developed method, experimental conditions were deliberately altered and the system suitability parameters were evaluated. Tailing factor for Gabapentin and Methylcobalamin was recorded.
The flow rate of the mobile phase was 1.0 ml/min, to study the effect of flow rate on the retention time; flow was changed by ± 0.2 units from 0.8 to 1.2 ml/min. The effect of the column temperature on retention time was studied at 30 ºC. 
CONCLUSION
The present results provide clear evidence that the proposed method can be successfully used for simultaneous determination of drug content in marketed formulations.
